Mason Street Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-24,059
Closed -$2.16M 373
2020
Q4
$2.16M Sell
24,059
-18
-0.1% -$1.65K 0.04% 587
2020
Q3
$2.49M Buy
24,077
+7,347
+44% +$792K 0.05% 425
2020
Q2
$1.32M Buy
16,730
+1,446
+9% +$108K 0.03% 698
2020
Q1
$884K Hold
15,284
0.02% 778
2019
Q4
$825K Buy
15,284
+391
+3% +$21.2K 0.02% 964
2019
Q3
$779K Sell
14,893
-205
-1% -$9.55K 0.02% 947
2019
Q2
$729K Buy
15,098
+628
+4% +$30.1K 0.02% 981
2019
Q1
$731K Buy
14,470
+547
+4% +$32.3K 0.01% 1005
2018
Q4
$825K Buy
13,923
+880
+7% +$56.7K 0.02% 865
2018
Q3
$859K Buy
13,043
+2,828
+28% +$165K 0.02% 920
2018
Q2
$516K Buy
10,215
+484
+5% +$25.2K 0.01% 1066
2018
Q1
$512K Buy
9,731
+580
+6% +$28.9K 0.01% 1024
2017
Q4
$425K Buy
9,151
+279
+3% +$11.7K 0.01% 1078
2017
Q3
$359K Buy
8,872
+287
+3% +$10.4K 0.01% 1124
2017
Q2
$291K Buy
8,585
+498
+6% +$15.4K 0.01% 1171
2017
Q1
$235K Buy
8,087
+564
+7% +$17.2K 0.01% 1215
2016
Q4
$247K Buy
7,523
+443
+6% +$13.3K 0.01% 1177
2016
Q3
$223K Buy
7,080
+971
+16% +$28.2K 0.01% 1174
2016
Q2
$172K Buy
6,109
+636
+12% +$24.9K 0.01% 1219
2016
Q1
$199K Buy
5,473
+577
+12% +$20.4K 0.01% 1137
2015
Q4
$196K Buy
4,896
+437
+10% +$15.2K 0.01% 1110
2015
Q3
$127K Buy
4,459
+326
+8% +$10.7K ﹤0.01% 1225
2015
Q2
$136K Buy
4,133
+206
+5% +$6.39K ﹤0.01% 1225
2015
Q1
$113K Buy
3,927
+159
+4% +$4.56K ﹤0.01% 1262
2014
Q4
$103K Buy
3,768
+120
+3% +$2.86K ﹤0.01% 1678
2014
Q3
$78K Sell
3,648
-67
-2% -$1.53K ﹤0.01% 1731
2014
Q2
$83K Buy
3,715
+168
+5% +$3.91K ﹤0.01% 1712
2014
Q1
$90K Sell
3,547
-1,023
-22% -$25.8K ﹤0.01% 1668
2013
Q4
$105K Buy
4,570
+357
+8% +$7.44K ﹤0.01% 1684
2013
Q3
$80K Buy
4,213
+660
+19% +$11.8K ﹤0.01% 1587
2013
Q2
$51K Buy
+3,553
New +$51.4K ﹤0.01% 1609

Other funds holding EBS